These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 29107789)
1. Overcoming the Challenges of Low Drug Solubility in the Intravenous Formulation of Solithromycin. Evans D; Yalkowsky S; Wu S; Pereira D; Fernandes P J Pharm Sci; 2018 Jan; 107(1):412-418. PubMed ID: 29107789 [TBL] [Abstract][Full Text] [Related]
2. SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia. File TM; Rewerska B; Vucinic-Mihailovic V; Gonong JRV; Das AF; Keedy K; Taylor D; Sheets A; Fernandes P; Oldach D; Jamieson BD Clin Infect Dis; 2016 Oct; 63(8):1007-1016. PubMed ID: 27448679 [TBL] [Abstract][Full Text] [Related]
3. Solithromycin monotherapy for treatment of community-acquired bacterial pneumonia: A meta-analysis of randomised controlled trials. Wen J; Chen F; Zhao M; Wang X Int J Clin Pract; 2019 May; 73(5):e13333. PubMed ID: 30810253 [TBL] [Abstract][Full Text] [Related]
4. Solithromycin: A novel ketolide antibiotic. Buege MJ; Brown JE; Aitken SL Am J Health Syst Pharm; 2017 Jun; 74(12):875-887. PubMed ID: 28432048 [TBL] [Abstract][Full Text] [Related]
6. The solithromycin journey-It is all in the chemistry. Fernandes P; Martens E; Bertrand D; Pereira D Bioorg Med Chem; 2016 Dec; 24(24):6420-6428. PubMed ID: 27595539 [TBL] [Abstract][Full Text] [Related]
7. Solithromycin (CEM-101): A New Fluoroketolide Antibiotic and Its Role in the Treatment of Gonorrhea. Mancuso AM; Gandhi MA; Slish J J Pharm Pract; 2018 Apr; 31(2):195-201. PubMed ID: 28490220 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL). Barrera CM; Mykietiuk A; Metev H; Nitu MF; Karimjee N; Doreski PA; Mitha I; Tanaseanu CM; Molina JM; Antonovsky Y; Van Rensburg DJ; Rowe BH; Flores-Figueroa J; Rewerska B; Clark K; Keedy K; Sheets A; Scott D; Horwith G; Das AF; Jamieson B; Fernandes P; Oldach D; Lancet Infect Dis; 2016 Apr; 16(4):421-30. PubMed ID: 26852726 [TBL] [Abstract][Full Text] [Related]
9. The role of solithromycin in the management of bacterial community-acquired pneumonia. Van Bambeke F; Tulkens PM Expert Rev Anti Infect Ther; 2016; 14(3):311-24. PubMed ID: 26848612 [TBL] [Abstract][Full Text] [Related]
10. Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia. Lang JE; Hornik CP; Elliott C; Silverstein A; Hornik C; Al-Uzri A; Bosheva M; Bradley JS; Borja-Tabora CFC; Di John D; Mendez Echevarria A; Ericson JE; Friedel D; Gonczi F; Isidro MGD; James LP; Kalocsai K; Koutroulis I; Laki I; Ong-Lim ALT; Nad M; Simon G; Syed S; Szabo E; Benjamin DK; Cohen-Wolkowiez M; Pediatr Infect Dis J; 2022 Jul; 41(7):556-562. PubMed ID: 35675525 [TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia. Oldach D; Clark K; Schranz J; Das A; Craft JC; Scott D; Jamieson BD; Fernandes P Antimicrob Agents Chemother; 2013 Jun; 57(6):2526-34. PubMed ID: 23507282 [TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents. Gonzalez D; James LP; Al-Uzri A; Bosheva M; Adler-Shohet FC; Mendley SR; Bradley JS; Espinosa C; Tsonkova E; Moffett K; Marquez L; Simonsen KA; Stoilov S; Boakye-Agyeman F; Jasion T; Hornik CP; Hernandez R; Benjamin DK; Cohen-Wolkowiez M Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891609 [TBL] [Abstract][Full Text] [Related]
13. Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy. Donald BJ; Surani S; Deol HS; Mbadugha UJ; Udeani G Drug Des Devel Ther; 2017; 11():3559-3566. PubMed ID: 29263651 [TBL] [Abstract][Full Text] [Related]
14. Alternative approaches utilizing click chemistry to develop next-generation analogs of solithromycin. Daher SS; Lee M; Jin X; Teijaro CN; Barnett PR; Freundlich JS; Andrade RB Eur J Med Chem; 2022 Apr; 233():114213. PubMed ID: 35240514 [TBL] [Abstract][Full Text] [Related]
15. A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea. Hook EW; Golden M; Jamieson BD; Dixon PB; Harbison HS; Lowens S; Fernandes P Clin Infect Dis; 2015 Oct; 61(7):1043-8. PubMed ID: 26089222 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, Biological Evaluation, and Computational Analysis of Biaryl Side-Chain Analogs of Solithromycin. Daher SS; Lee M; Jin X; Teijaro CN; Wheeler SE; Jacobson MA; Buttaro B; Andrade RB ChemMedChem; 2021 Nov; 16(21):3368-3373. PubMed ID: 34355515 [TBL] [Abstract][Full Text] [Related]